These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35318645)

  • 21. A novel method using ambient glutamate for the electrophysiological quantification of extrasynaptic NMDA receptor function in acute brain slices.
    Moldavski A; Behr J; Bading H; Bengtson CP
    J Physiol; 2020 Feb; 598(4):633-650. PubMed ID: 31876958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3beta -hydroxypregnane steroids are pregnenolone sulfate-like GABA(A) receptor antagonists.
    Wang M; He Y; Eisenman LN; Fields C; Zeng CM; Mathews J; Benz A; Fu T; Zorumski E; Steinbach JH; Covey DF; Zorumski CF; Mennerick S
    J Neurosci; 2002 May; 22(9):3366-75. PubMed ID: 11978813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurosteroid modulation of recombinant rat alpha5beta2gamma2L and alpha1beta2gamma2L GABA(A) receptors in Xenopus oocyte.
    Rahman M; Lindblad C; Johansson IM; Bäckström T; Wang MD
    Eur J Pharmacol; 2006 Oct; 547(1-3):37-44. PubMed ID: 16934248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neuroactive steroid pregnenolone sulfate stimulates trafficking of functional N-methyl D-aspartate receptors to the cell surface via a noncanonical, G protein, and Ca2+-dependent mechanism.
    Kostakis E; Smith C; Jang MK; Martin SC; Richards KG; Russek SJ; Gibbs TT; Farb DH
    Mol Pharmacol; 2013 Aug; 84(2):261-74. PubMed ID: 23716622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steroid potentiation and inhibition of N-methyl-D-aspartate receptor-mediated intracellular Ca++ responses: structure-activity studies.
    Irwin RP; Lin SZ; Rogawski MA; Purdy RH; Paul SM
    J Pharmacol Exp Ther; 1994 Nov; 271(2):677-82. PubMed ID: 7965782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-methyl-D-aspartate receptor hypofunction as a potential contributor to the progression and manifestation of many neurological disorders.
    Dong B; Yue Y; Dong H; Wang Y
    Front Mol Neurosci; 2023; 16():1174738. PubMed ID: 37396784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive Modulators of the N-Methyl-d-aspartate Receptor: Structure-Activity Relationship Study of Steroidal 3-Hemiesters.
    Krausova B; Slavikova B; Nekardova M; Hubalkova P; Vyklicky V; Chodounska H; Vyklicky L; Kudova E
    J Med Chem; 2018 May; 61(10):4505-4516. PubMed ID: 29708744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiprodil, a selective GluN2B negative allosteric modulator, rescues audiogenic seizures in mice carrying the GluN2A(N615S) mutation.
    Bertocchi I; Cifarelli L; Oberto A; Eva CE; Sprengel R; Mirza NR; Muglia P
    Br J Pharmacol; 2024 Jun; 181(12):1886-1894. PubMed ID: 38529699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of
    Strong KL; Epplin MP; Ogden KK; Burger PB; Kaiser TM; Wilding TJ; Kusumoto H; Camp CR; Shaulsky G; Bhattacharya S; Perszyk RE; Menaldino DS; McDaniel MJ; Zhang J; Le P; Banke TG; Hansen KB; Huettner JE; Liotta DC; Traynelis SF
    ACS Chem Neurosci; 2021 Jan; 12(1):79-98. PubMed ID: 33326224
    [No Abstract]   [Full Text] [Related]  

  • 30. Whole-cell patch-clamp analysis of recombinant NMDA receptor pharmacology using brief glutamate applications.
    Glasgow NG; Johnson JW
    Methods Mol Biol; 2014; 1183():23-41. PubMed ID: 25023300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential responses of disease-related GRIN variants located in pore-forming M2 domain of N-methyl-D-aspartate receptor to FDA-approved inhibitors.
    Song R; Zhang J; Perszyk RE; Camp CR; Tang W; Kannan V; Li J; Xu Y; Chen J; Li Y; Liang SH; Traynelis SF; Yuan H
    J Neurochem; 2024 Dec; 168(12):3936-3949. PubMed ID: 37649269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: implications for neuropsychiatric diseases.
    Lin H; Hsu FC; Baumann BH; Coulter DA; Lynch DR
    Neurobiol Dis; 2014 Mar; 63():129-40. PubMed ID: 24326163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel allosteric modulator binding sites in NMDA receptors: A molecular modeling study.
    Kane LT; Costa BM
    J Mol Graph Model; 2015 Sep; 61():204-13. PubMed ID: 26280688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of steroids on NMDA receptors and excitatory synaptic transmission in neonatal motoneurons in rat spinal cord slices.
    Abdrachmanova G; Chodounská H; Vyklický L
    Eur J Neurosci; 2001 Aug; 14(3):495-502. PubMed ID: 11553299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel family of negative and positive allosteric modulators of NMDA receptors.
    Costa BM; Irvine MW; Fang G; Eaves RJ; Mayo-Martin MB; Skifter DA; Jane DE; Monaghan DT
    J Pharmacol Exp Ther; 2010 Dec; 335(3):614-21. PubMed ID: 20858708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Integrated Approach for Screening and Identification of Positive Allosteric Modulators of N-Methyl-D-Aspartate Receptors.
    Jambrina E; Cerne R; Smith E; Scampavia L; Cuadrado M; Findlay J; Krambis MJ; Wakulchik M; Chase P; Brunavs M; Burris KD; Gallagher P; Spicer TP; Ursu D
    J Biomol Screen; 2016 Jun; 21(5):468-79. PubMed ID: 26838761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steroid structure and pharmacological properties determine the anti-amnesic effects of pregnenolone sulphate in the passive avoidance task in rats.
    Vallée M; Shen W; Heinrichs SC; Zorumski CF; Covey DF; Koob GF; Purdy RH
    Eur J Neurosci; 2001 Dec; 14(12):2003-10. PubMed ID: 11860495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function.
    Santos-Gómez A; Miguez-Cabello F; García-Recio A; Locubiche-Serra S; García-Díaz R; Soto-Insuga V; Guerrero-López R; Juliá-Palacios N; Ciruela F; García-Cazorla À; Soto D; Olivella M; Altafaj X
    Hum Mol Genet; 2021 Feb; 29(24):3859-3871. PubMed ID: 33043365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of GABA(A) receptor function by neuroactive steroids: evidence for heterogeneity of steroid sensitivity of recombinant GABA(A) receptor isoforms.
    Maitra R; Reynolds JN
    Can J Physiol Pharmacol; 1998 Sep; 76(9):909-20. PubMed ID: 10066142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered zinc sensitivity of NMDA receptors harboring clinically-relevant mutations.
    Serraz B; Grand T; Paoletti P
    Neuropharmacology; 2016 Oct; 109():196-204. PubMed ID: 27288002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.